Neo-ASA
H-40143
Unknown other completed
Quick answer
Neo-ASA for Argininosuccinate Lyase Deficiency is a Unknown program (other) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Argininosuccinate Lyase Deficiency
- Phase
- Unknown
- Modality
- other
- Status
- completed